扶正法、祛邪法对Lewis肺癌小鼠的抑瘤作用及机制研究  被引量:2

Study of the Anti-tumor Effect and Mechanism of Strengthening Healthy Qi and Eliminating Pathogenic Factors on Mice Model with Lewis Lung Cancer

在线阅读下载全文

作  者:齐元富[1] 张盈盈[2] 李慧杰[1] 郑祎[2] 刘寨东[1] 

机构地区:[1]山东中医药大学附属医院,山东济南250014 [2]山东中医药大学,山东济南250355

出  处:《山东中医杂志》2016年第1期61-63,共3页Shandong Journal of Traditional Chinese Medicine

基  金:山东省中医药科技发展计划(编号:2009Z003)

摘  要:目的:研究扶正法、祛邪法对Lewis肺癌小鼠的抑瘤作用并探讨其作用机制。方法:建立Lewis肺癌小鼠移植瘤模型,按实验分组干预,计算各组抑瘤率,免疫组化法检测BCL-2表达情况,RT-PCR法检测Caspase-3 m RNA、Survivin m RNA表达情况。结果:芪贞固本方、芩莲正积方均有不同程度的抑瘤作用,其抑瘤率分别为18.42%、29.24%,两组比较差异无统计学意义(P>0.05);二方均可促进Caspase-3 m RNA的表达,抑制BCL-2、Survivin m RNA的表达,与对照组比较有显著统计学意义(P<0.05),但均不及DDP组。结论:芪贞固本方和芩莲正积方确有抗肿瘤作用,芩莲正积方作用略强,其机制可能为促进Caspase-3m RNA的表达,抑制BCL-2、Survivin m RNA的表达。Objective:To study of the anti-tumor effect and mechanism of strengthening healthy Qi and eliminating pathogenic factors on mice model with Lewis lung cancer. Method:The Lewis lung cancer mouse model was established,the mic were divided into different groups and given intervention. The anti-tumor rate of each group was calculated,the expression of BCL-2 in tumor cells was measured with immunohistochemistry,the expressions of caspase-3 mRNA,surviving mRNA were detected with real-time PCR. Results:Qizhen guben formula and Qinlian zhengji formula all had certain anti-tumor effect,with the anti-rate 18.42% and 29.24% respectively,and there were no significant differences between two groups(P〉0.05). When compared to the control group,they all could significantly promote the expression of caspase mRNA and down-regulate the expression of BCL-2 survivin mRNA,but the their effect was not better than cisplatin. Conclusion:Qizhen gubeu formula and Qinlian zhengji formula did possess anti-tumor effect and this effect of Qinlian Zhengji formual was stronger, Their mechanism of action may be related to promoting the expression of caspase mRNA and down-regulating the expression of BCL-2 and survivin mRNA.

关 键 词:扶正法 祛邪法 肺癌 机制 小鼠 

分 类 号:R285.6[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象